The Medicare Part D prescription drug benefit has certainly endured its share of recent controversy. Democrats have lambasted the plan as an inordinately confusing, bureaucratic handout to the pharmaceutical industry, while fiscal conservatives in both parties have derided the benefit's astonishing multibillion-dollar price tag. Earlier this year, regular news reports surfaced recounting horror stories of small-town pharmacists forced to pay for patients' prescriptions and seniors getting ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.